Canada Pharmacies Alert on the FDA Approval Postponement of Adasuve from Alexzas - PR-USA.net

Adasuve is an inhaler containing loxapine as the active ingredient and uses Alexzas Staccato system to deliver the drug in perfectly sized particles to the lungs. Alexza applied to FDA for approval of Adasuve in 2009. After FDA turned down the application ...

Alexza Reports 2012 First Quarter Financial Results and Provides Business Update - Yahoo Finance

A replay of the call will be available for two weeks following the event. About Alexza Pharmaceuticals, Inc. ADASUVE™ (Staccato loxapine) is Alexza's lead program, which is being developed for the acute treatment of agitation associated with ...

Alexza 2012 Q1 Earnings Release Conference Call - Yahoo! Finance

The company’s clinical-stage product candidates comprise AZ-004 (staccato loxapine), which is licensed to Biovail Laboratories International SRL for the acute treatment of agitation in patients with schizophrenia or bipolar disorder; AZ-007 (staccato ...

Biotech Industry Hotbed of Merger & Acquisition Speculation - Yahoo Finance

The company recently received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application for ADASUVE (loxapine) inhalation powder. Alexza plans to meet with the FDA to gain a better ...

Alexza Receives Complete Response Letter for Adasuve™ NDA - Boston Globe

for ADASUVE™ (loxapine) inhalation powder, 5 mg and 10 mg.  The CRL was issued by FDA's Center for Drug Evaluation and Research indicating that the NDA review cycle is complete and the application is not ready for approval in its present form. 

Latest topics referred to NICE: May 2012 - Department of Health

To appraise the clinical and cost effectiveness of loxapine inhalation for the treatment of acute agitation and disturbed behaviours in people with schizophrenia or bipolar disorder. Read about NICE technology appraisals on the NICE website. NICE is an ...

Increased risk of death associated with off-label use of antipsychotic drugs to treat psicosis in older people with dementia - Xagena Medical News

The medications involved in this action are: Compazine ( Prochlorperazine ), Abilify ( Aripiprazole ), Haldol ( Haloperidol ), Clozaril ( Clozapine ), Loxitane ( Loxapine ), FazaClo ( Clozapine ), Mellaril ( Thioridazine ), Geodon ( Ziprasidone ), Moban ...

Biotech Industry Hotbed of Merger & Acquisition Speculation Five Star Equities Provides Stock Research on - PR Inside

The company recently received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application for ADASUVE (loxapine) inhalation powder. Alexza plans to meet with the FDA to gain a better understanding of ...